Article thumbnail

Cost effectiveness and cost utility of the noncoding blood glucose meter CONTOUR® TS

By Przemyslaw Holko and Pawal Kawalec
Topics: Original Research
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. Age does not influence levels of HbA1c in normal subject.
  2. (2008). Assessment Agency website [homepage on the I nternet]. Available from: Accessed
  3. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ.
  4. (2007). Bayer HealthCare Diabetes Care;
  5. (1998). Better glycaemic control and risk reduction of diabetic complications in Type 2 diabetes: comparison with the DCCT. Diabetes Res Clin Pract.
  6. (2011). Central Statistical Office of Poland. National Census of People and Dwellings
  7. (2008). Clinical Research and Health Policy Studies. The Cost Effectiveness Analysis Registry Database, Center for the Evaluation of Value and Risk
  8. Effect of improved glycemic control on health care costs and utilization.
  9. (2010). Federation. Diabetes Atlas. Diabetes [homepage on the Internet]. Available from: diabetes. Accessed
  10. Glycemic control and the initiation and progression of the complications of diabetes mellitus.
  11. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial.
  12. (2006). New insights into glucose regulation. Diabetes Educ.
  13. (2008). Portal [homepage on the Internet]. Available from: Accessed
  14. (2001). Potential short-term economic benefits of improved g lycemic control: a managed care perspective. Diabetes Care.
  15. Prevention of the complications of diabetes.
  16. Significant insulin dose errors may occur if blood glucose results are obtained from miscoded meters.
  17. (2004). Standardized evaluation of instruments for self-monitoring of blood glucose by patients and a technologist. Clin Chem.
  18. (2004). Tests of glycemia in diabetes. Diabetes Care.
  19. (2004). The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin.
  20. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and p rogression of long-term complications in insulin-dependent diabetes mellitus.
  21. (1999). Wplyw cukrzycy na wsakaŸniki chorobowoœci I œmiertelnoœcu w powodu ostrego zawalu serca. Medycyna Metaboliczna.